NASDAQ:AMIX Autonomix Medical Q3 2025 Earnings Report $4.12 +0.05 (+1.11%) As of 03:37 PM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast Autonomix Medical EPS ResultsActual EPS-$30.66Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AAutonomix Medical Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AAutonomix Medical Announcement DetailsQuarterQ3 2025Date2/13/2025TimeBefore Market OpensConference Call DateThursday, February 13, 2025Conference Call Time7:00AM ETUpcoming EarningsAutonomix Medical's Q2 2027 earnings is estimated for Wednesday, November 11, 2026, based on past reporting schedules, with a conference call scheduled on Monday, November 9, 2026 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesQuarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q) Autonomix Medical Earnings HeadlinesAMIX Share News TodaySeptember 24 at 7:14 PM | uk.investing.comAutonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation PlatformSeptember 24 at 8:30 AM | globenewswire.comDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.September 25 at 1:00 AM | Stansberry Research (Ad)Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of DirectorsSeptember 16, 2026 | globenewswire.comAutonomix Medical (NASDAQ:AMIX) Stock Rating Lowered by Wall Street ZenSeptember 14, 2026 | americanbankingnews.comAutonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026September 1, 2026 | globenewswire.comSee More Autonomix Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Autonomix Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Autonomix Medical and other key companies, straight to your email. Email Address About Autonomix MedicalAutonomix Medical (NASDAQ:AMIX) is a medical device company developing catheter-based technologies intended to diagnose and treat conditions involving the peripheral nervous system. The company’s platform uses a miniature sensing chip integrated into a catheter to detect and measure nerve signals in targeted areas of the body. Autonomix is initially focused on applications in pain management, including the detection and treatment of nerves associated with chronic and cancer-related pain. Its technology is designed to help physicians identify relevant nerves more precisely and guide procedures such as targeted nerve ablation or other therapeutic interventions. The company’s development programs remain subject to clinical testing, regulatory review and authorization before any products can be broadly commercialized. Autonomix Medical is headquartered in the United States and focuses primarily on developing its platform for use by physicians and healthcare providers.View Autonomix Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Costco Ends Its Fiscal Year on a High Note, Eyes Big ExpansionCracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic ProblemSuper Micro’s Vera Rubin Shipments Put Its AI Infrastructure Advantage to the TestHims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks3 Space Stocks to Watch as SpaceX Reshapes the Launch MarketOil May Be Stronger Than It Looks—And Diamondback Is on SaleBlackBerry Shifts Gears With Coretura Deal Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
